Timothy Keutzer - Aug 28, 2023 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
Chief Development Officer
Signature
/s/ Tamara Joseph, Attorney-in-Fact for Timothy Keutzer
Stock symbol
SPRO
Transactions as of
Aug 28, 2023
Transactions value $
-$2,336
Form type
4
Date filed
8/30/2023, 04:23 PM
Previous filing
Feb 3, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Sale -$2.34K -1.85K -0.57% $1.26 325K Aug 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on August 26, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement.